about
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease.Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.Neurological complications of Behçet's syndrome.Behçet's disease: review with emphasis on dermatological aspects.Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
New therapeutic solutions for Behçet's syndrome.
@en
type
label
New therapeutic solutions for Behçet's syndrome.
@en
prefLabel
New therapeutic solutions for Behçet's syndrome.
@en
P2093
P2860
P50
P1476
New therapeutic solutions for Behçet's syndrome.
@en
P2093
Antonio Vitale
Donato Rigante
Giacomo Emmi
Giuseppe Lopalco
Maria Teresa Bianco
P2860
P304
P356
10.1080/13543784.2016.1181751
P407
P577
2016-05-10T00:00:00Z